注册 | 登录 | 充值

返回首页
找到约 8 条结果

JUPITER试验受试者基线特征,他汀类治疗低LDL

    Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Trial Study Group.    JUPITER Coord..... 
学术资讯 - 临床研究

JUPITER试验:初始浓度升高后追踪高敏C

Glynn RJ, MacFadyen JG, Ridker PM.    Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Division of Cardiovascular Medicine,   Brigham and Women’s Hospital, Harvard Medical School..... 
学术资讯 - 临床研究

JUPITER试验性别

Samia Mora1; Robert J Glynn2; Paul M Ridker3 1 Harvard Sch of Medicine, Boston, MA2 Harvard Sch of Public Health, Boston, MA3 Harvard Sch of Medicine, Boston, MA     Background Statin therapy in women without ma..... 
学术资讯 - 临床研究

JUPITER试验:稳定型冠心病患者血清C

    Saely CH, Rein P, Vonbank A, Drexel H.Abstract    BACKGROUND: The JUPITER trial has recently demonstrated an outstanding reduction of cardiovascular events by 20 mg rosuvastatin/day in subjects with high CRP..... 
学术资讯 - 临床研究

JUPITER试验:强效他汀治疗后HDL

    Ridker PM, Genest J, Boekholdt SM, Libby P, Gotto AM, Nordestgaard BG, Mora S, MacFadyen JG, Glynn RJ, Kastelein JJ; JUPITER Trial Study Group.    Center for Cardiovascular Disease Prevention, Brigham..... 
学术资讯 - 临床研究

JUPITER试验:心血管疾病高危患者应用瑞苏伐他汀的成本效益分析

    Ohsfeldt RL, Gandhi SK, Smolen LJ, Jensen MM, Fox KM, Gold A, Hsia J.    Texas A&M Health Science Center, College Station, TX, USA.Abstract    Abstract Objective: This study assessed the long-term c..... 
学术资讯 - 临床研究

JUPITER试验:肥胖、C反应蛋白与亚临床动脉粥样硬化的相关性:动脉粥样硬化的多种族研究(MESA)

Michael J Blaha1; Juan J Rivera1; Matthew Budoff2; Ron Blankstein3; Arthur Agatston4; Dan H O’Leary5; Roger S Blumenthal6; Khurram Nasir6 1 Johns Hopkins Hosp, Baltimore, MD2 Los Angeles Biomedical Rsch ..... 
学术资讯 - 临床研究

JUPITER分析有助于平息对他汀引发糖尿病的恐惧

  2012年8月11日Lancet发表的一篇报告称,JUPITER试验中他汀疗法引发糖尿病的风险仅限于那些有发生糖尿病高危因素的患者,如空腹血糖受损(IFG)、代谢综合征、严重肥胖或HbA1c水平升高者。但是即使这些高危患者,他汀治疗的..... 
学术资讯 - 临床医学